As shown in Figure 5B, SIGLEC12 levels were correlated positively with pro-tumor immune subsets, Tregs (Rho = 0.151, p = 3.61 × 10−3), M0 macrophages (Rho = 0.170, p = 1.07 × 10−3), and M2 macrophages (Rho = 0.454, p = 4.20 × 10−20). The gene discussed is SIGLEC12; the disease is neoplasm.